Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study.
Houillier C, Dureau S, Taillandier L, Houot R, Chinot O, Moluçon-Chabrot C, Schmitt A, Gressin R, Choquet S, Damaj G, Peyrade F, Abraham J, Delwail V, Gyan E, Sanhes L, Cornillon J, Garidi R, Delmer A, Al Jijakli A, Morel P, Waultier A, Paillassa J, Chauchet A, Gastinne T, Laadhari M, Plissonnier AS, Feuvret L, Cassoux N, Touitou V, Ricard D, Hoang-Xuan K, Soussain C; LOC Network for CNS Lymphoma. Houillier C, et al. Among authors: soussain c. J Clin Oncol. 2022 Nov 10;40(32):3692-3698. doi: 10.1200/JCO.22.00491. Epub 2022 Jul 14. J Clin Oncol. 2022. PMID: 35834762 Clinical Trial.
Recent advances in primary CNS lymphoma.
Hoang-Xuan K, Camilleri-Broët S, Soussain C. Hoang-Xuan K, et al. Among authors: soussain c. Curr Opin Oncol. 2004 Nov;16(6):601-6. doi: 10.1097/01.cco.0000142927.88773.7e. Curr Opin Oncol. 2004. PMID: 15627024 Review.
Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.
Soussain C, Hoang-Xuan K, Taillandier L, Fourme E, Choquet S, Witz F, Casasnovas O, Dupriez B, Souleau B, Taksin AL, Gisselbrecht C, Jaccard A, Omuro A, Sanson M, Janvier M, Kolb B, Zini JM, Leblond V; Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire. Soussain C, et al. J Clin Oncol. 2008 May 20;26(15):2512-8. doi: 10.1200/JCO.2007.13.5533. Epub 2008 Apr 14. J Clin Oncol. 2008. PMID: 18413641 Clinical Trial.
[Neurological damage of brain tumor therapy].
Ricard D, De Greslan T, Soussain C, Bounolleau P, Sallansonnet-Froment M, Delmas JM, Taillia H, Martin-Duverneuil N, Renard JL, Hoang-Xuan K. Ricard D, et al. Among authors: soussain c. Rev Neurol (Paris). 2008 Jun-Jul;164(6-7):575-87. doi: 10.1016/j.neurol.2008.03.014. Epub 2008 Jun 9. Rev Neurol (Paris). 2008. PMID: 18565357 Review. French.
Primary CNS lymphoma in immunocompetent patients.
Sierra del Rio M, Rousseau A, Soussain C, Ricard D, Hoang-Xuan K. Sierra del Rio M, et al. Among authors: soussain c. Oncologist. 2009 May;14(5):526-39. doi: 10.1634/theoncologist.2008-0236. Epub 2009 May 11. Oncologist. 2009. PMID: 19433528 Free article. Review.
CNS complications of radiotherapy and chemotherapy.
Soussain C, Ricard D, Fike JR, Mazeron JJ, Psimaras D, Delattre JY. Soussain C, et al. Lancet. 2009 Nov 7;374(9701):1639-51. doi: 10.1016/S0140-6736(09)61299-X. Lancet. 2009. PMID: 19897130 Review.
125 results